Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Herman Dieperink

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|September 5, 2014
[In Process Citation]Hans Herman Dieperink, Bo Feldt-Rasmussen, Jeppe Hagstrup Christensen
Clinical Transplantation|August 28, 2025
Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry AnalysisAnja Gaeckler, Imad Al-Dakkak, Nuria Saval, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|September 5, 2014
[In Process Citation]Hans Herman Dieperink, Bo Feldt-Rasmussen, Jeppe Hagstrup Christensen
Clinical Transplantation|August 28, 2025
Effectiveness and Safety of Switching to Ravulizumab From Eculizumab in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome: A Global aHUS Registry AnalysisAnja Gaeckler, Imad Al-Dakkak, Nuria Saval, et al.
Pageof 1